The Role of VitD in Rehabilitation of Idiopathic Adolescent Scoliosis
Launched by UNIVERSITY OF IOANNINA · Jul 9, 2018
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the role of vitamin D in helping teenagers with idiopathic adolescent scoliosis, which is a condition where the spine curves abnormally without a known cause. Researchers want to find out if vitamin D can help improve the condition and restore a normal spinal shape. The study is currently looking for participants between the ages of 12 and 18 who have a specific type of scoliosis and meet certain medical criteria.
To be eligible for the trial, participants should have idiopathic adolescent scoliosis and show a certain level of bone maturity, determined by a Risser sign of less than 3-4. However, those with certain other health issues, like neuromuscular diseases or problems with their liver or thyroid, cannot participate. If chosen, participants will be involved in a study that may help improve treatments for scoliosis in the future. It's a chance to contribute to important research while possibly benefiting from vitamin D as part of their rehabilitation.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Idiopathic Adolescent Scoliosis
- • Risser sign \<3-4
- Exclusion Criteria:
- • Neuromuscular diseases
- • metabolic disease
- • Liver, lung, thyroid and parathyroid gland disorders.
About University Of Ioannina
The University of Ioannina, located in Greece, is a leading academic institution renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative studies aimed at improving healthcare outcomes. With a focus on collaborative research, the University of Ioannina engages in multidisciplinary partnerships and adheres to rigorous ethical standards, ensuring the integrity and reliability of its clinical trials. Through its dedication to scientific excellence, the university aims to contribute significantly to the body of medical knowledge and the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Asvestochori, , Greece
Ioannina, , Greece
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials